These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

47 related items for PubMed ID: 13438302

  • 1. [Anti-tuberculosis action of calcium salt of N-benzoyl-paraaminosalicylic acid].
    MONCALVO F.
    G Ital Della Tuberc; 1957; 11(1):48-55. PubMed ID: 13438302
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Blood levels of paraaminosalicylic acid (PAS) in patients with pulmonary tuberculosis. II. Production and clinical use of the potassium salt of paraaminosalicylic acid (K-PAS)].
    OSINSKA K, KORKUCZANSKI A, WARESKA W.
    Gruzlica (1926); 1958 Jun; 26(6):473-8. PubMed ID: 13562667
    [No Abstract] [Full Text] [Related]

  • 5. The tolerability of calcium benzoyl-PAS and calcium PAS; a double blind study.
    JEKER K, LAUENER H, REGLI J, FRIEDRICH T.
    Am Rev Tuberc; 1959 Mar; 79(3):351-6. PubMed ID: 13627443
    [No Abstract] [Full Text] [Related]

  • 6. [Onset of pulmonary tuberculosis and paraaminosalicylic acid, PAS].
    DE BEULE R.
    Brux Med; 1952 Mar 02; 32(9):443-51. PubMed ID: 14905075
    [No Abstract] [Full Text] [Related]

  • 7. [Utilization of p-aminosalicylic acid hydrazide in pulmonary tuberculosis; results of 15 observations].
    HENROT L.
    Ann Soc Belg Med Trop (1920); 1957 Dec 31; 37(6):851-9. PubMed ID: 13534146
    [No Abstract] [Full Text] [Related]

  • 8. [Cyanacetic acid hydrazide associated with dihydrostreptomycin in the treatment of pulmonary tuberculosis].
    SEREMBE M.
    Minerva Med; 1957 Sep 15; 48(74):2931-5. PubMed ID: 13483308
    [No Abstract] [Full Text] [Related]

  • 9. [Combined thiosemicarbazone-streptomycin-paraaminosalicylic acid therapy in tuberculosis].
    TODOROFF T.
    G Ital Tuberc Mal Torace; 1951 Sep 15; 5(5):354-63. PubMed ID: 14906820
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Observations with cyanocetyl hydrazide PAS compound in pulmonary tuberculosis.
    TANDON RN, SARKAR SK, NARANG RK.
    J Indian Med Assoc; 1957 May 16; 28(10):424-6. PubMed ID: 13439188
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical report on several cases of pulmonary tuberculosis treated with PAS hydrazide].
    NICOLAI F.
    G Ital Chemioter; 1954 May 16; 1(3-4):609-10. PubMed ID: 14391685
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Bacteriology and pharmacology of benzoyl-paraaminosalicylic acid].
    SCHONHOLZER G, LAUENER H, HURNI H.
    Schweiz Med Wochenschr; 1955 Mar 05; 85(10):222-8. PubMed ID: 14358639
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Comparative study of the tolerance of orally administered PAS-calcium and benzoyl-PAS-calcium in therapy of pulmonary tuberculosis].
    JEKER K.
    Schweiz Z Tuberc Pneumonol; 1958 Mar 05; 15(4):211-3. PubMed ID: 13602780
    [No Abstract] [Full Text] [Related]

  • 18. [Stability of benzoyl-PAS and benzoyl-PAS calcium salt].
    WILLI AV.
    Arzneimittelforschung; 1957 Jan 05; 7(1):7-10. PubMed ID: 13412564
    [No Abstract] [Full Text] [Related]

  • 19. [Studies on the efficacy and mode of action of N-benzoyl-p-aminosalicylic acid (benzacyl)].
    LOEW M, KUNEKE S.
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957 Jan 05; 116(5):394-406. PubMed ID: 13426004
    [No Abstract] [Full Text] [Related]

  • 20. [UV-absorption spectra and quantitative determination of calcium salt of para-benzoyl-aminosalicylic acid (bepask)].
    Koval'chuk TV.
    Farm Zh; 1969 Jan 05; 24(5):62-6. PubMed ID: 5363000
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.